Intelligent Abstracting is Not Optional

Intelligent abstracting is not a theory.
It’s already happening.

Concurrent abstracting is no longer optional—it’s essential.  Many programs that continue to treat cancer registrars as end-of-line data collectors are falling behind. The solution is to deploy automation to transition cancer registrars into curators of data, processing more cases with higher accuracy and completeness in real time.

Deploying concurrent abstracting with intelligent systems means every step—casefinding, abstraction, follow-up, and quality review—happens continuously. Registrars validate, interpret, and add the nuance only humans can provide. Meanwhile, automation handles volume, standards compliance, better tools for cross-checking, and real-time insights.

The payoff? More cases completed per registrar, higher accuracy rates, and more timely insights. Quality monitoring is smoother and in real-time, researchers gain access to fresher data, and administrators see the cancer program as it exists today—not six months ago.

Real-world deployment transforms cancer registries from compliance engines into strategic tools. Programs that delay risk missing revenue, losing staff to burnout, and being sidelined in value-based care.  (Diaz, Becker’s Review, Health IT, 9/2/2025).

Is your registry still a back-office function—or a real-time hub of oncology quality leadership?

＼ Get the latest news ／